Argitalpenak
- Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease, 2018; 64(1), 117 - 136
- Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders. Biochem Pharmacol., 2018; Nov;157:258-265.
- Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis. Neuropharmacology., 2018; 141:181-191.
- Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease. Neuroscience, 2016; 329, 284 - 293
- Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo Glia, 2015; 63, 163 - 176
- Neurotransmitter receptors localization. From autoradiography to Imaging Mass Spectrometry ACS Chemical Neuroscience, 2015; 6, 362 - 373
- Effects of Galanin subchronic treatment on memory and muscarinic receptors Neuroscience, 2015; 293, 23 - 34
- Anatomical Location of LPA1 Activation and LPA Phospholipid Precursors in Rodent and Human Brain Journal of Neurochemistry, 2015; 134(3), 471 - 85
- Type-1 Cannabinoid receptor activity during Alzheimer's disease progression Journal of Alzheimer's Disease (JAD), 2014; 42, 761 - 766
- Galanin activated Gi/o-proteins in human and rat central nervous systems Neuropeptides, 2014; 48, 295 - 304
—
10 elementu orrialdeko